Signatures of recent activation identify a circulating T cell compartment containing tumor-specific antigen receptors with high avidity
Anna Purcarea(Institute of Medical Microbiology and Hygiene), Kilian Schober(Friedrich-Alexander-Universität Erlangen-Nürnberg), K Wagner(Institute of Medical Microbiology and Hygiene), John B.A.G. Haanen(Leiden University Medical Center), Sebastian Jarosch(Boehringer Ingelheim (Germany)), Joost H. van den Berg(The Netherlands Cancer Institute), Veit R. Buchholz(German Cancer Research Center), Monika Hammel(Institute of Medical Microbiology and Hygiene), Dirk H. Busch(German Center for Infection Research), Ludwig O. Pachmayr(Institute of Medical Microbiology and Hygiene), Anna Hochholzer(Institute of Medical Microbiology and Hygiene), Elvira D’Ippolito(Fondazione IRCCS Istituto Nazionale dei Tumori), Jack Barton(Institute of Medical Microbiology and Hygiene), Simon Grassmann(Technical University of Munich)
Cited by 30
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
|New England Journal of Medicine|2019|1.4k
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
|European Journal of Immunology|2019|1k